#None #Diabetes Care #MiniMed #Instinct Sensors

MiniMed Expands Diabetes Management Solutions in Europe

MiniMed, a recognized leader in the field of diabetes technology, has made a significant announcement: the introduction of the MiniMed™ 780G system paired with the Instinct sensor and the MiniMed Go™ system with the Instinct Go sensor. This launch, taking place across various European markets, aims to provide individuals managing diabetes with more robust and diverse options in their treatment regimens. The Instinct sensors are designed and manufactured by Abbott, a distinguished name in the healthcare sector, recognized for its innovative medical devices.

In recent years, there has been a growing demand for advanced diabetes technology, and MiniMed has been responsive to this need. The newly launched devices promise to offer not only flexibility but also enhanced performance, aligning with MiniMed's goal to simplify diabetes management and adapt to users' lifestyles.

Why Instinct Sensors?

Diabetes management can be a challenging endeavor, especially for those with type 1 diabetes, where meticulous carb counting and timely insulin administration are crucial. The MiniMed™ 780G system's integration with the Instinct sensor helps streamline this process. Notably, it employs Meal Detection™ technology, which is pivotal for reducing post-meal blood glucose spikes — a common issue when users forget or miscalculate their carb intake.

The Instinct sensor stands out as the world’s smallest and most discreet sensor, effectively designed to be worn comfortably for up to 15 days while delivering precise glucose measurements. In conjunction with the MiniMed™ 780G system, which adapts insulin delivery every five minutes, this combination allows for improved glycemic control, which is essential in diabetes management.

Recent studies published in reputable journals highlight that the glycemic outcomes achieved with the MiniMed™ 780G system using the Instinct sensor are comparable to those achieved with the previously used Simplera Sync™ sensor. This substantiates the reliable performance of the new sensors, ensuring that users can confidently manage their condition without compromising on accuracy.

The MiniMed Go™ System

For individuals who rely on multiple daily insulin injections (MDI), managing diabetes can often feel disjointed with various tools needing to be coordinated. The MiniMed Go™ system, equipped with the Instinct Go sensor, integrates the functionality of a smart insulin pen with real-time glucose monitoring. This innovative solution aims to eliminate the guesswork often associated with this regimen by providing users with alerts and actionable insights through its dedicated mobile app.

By streamlining diabetes management into a singular platform, MiniMed Go™ significantly enhances user experience. Healthcare professionals and users alike have noted that it minimizes mental load by consolidating information, thereby supporting better adherence to treatment plans.

A Word from Leadership

Que Dallara, CEO of MiniMed, articulated the company’s objective succinctly. He stated, “People with diabetes should not have to choose between flexibility and performance when managing their diabetes — and with MiniMed, they don't have to.” This philosophy is a driving force behind MiniMed’s continuous efforts to develop technologies that fit into users’ lives seamlessly rather than the other way around.

In conclusion, the expansion of MiniMed’s sensor offerings across Europe not only showcases their commitment to advancing diabetes care but also reflects a broader trend in healthcare technology that prioritizes patient-centered solutions. With a focus on maintaining proven outcomes, MiniMed is poised to make significant inroads in improving the lives of individuals living with diabetes. As the rollout progresses through European markets, it represents a hopeful advancement for countless diabetes patients seeking effective and flexible management solutions.

For further information on the MiniMed™ 780G and MiniMed Go™ systems, and to see how these new advancements can affect your diabetes management, visit the MiniMed official website.